Skip to content

A clinical study to evaluate the effectiveness of an Ayurvedic formulation in women with ovulation-related menstrual problems.

A Randomized Controlled Clinical Study To Assess The Efficacy Of Methikadya Churna In Vandhyatva With Special Reference To Anovulatory Cycles - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103113
Enrollment
92
Registered
2026-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Sponsors

YMT Ayurvedic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Known cases of infertility due to anovulation and polycystic ovarian disease 2 Patients with age between eighteen to forty years having infertility 3 Both primary and secondary infertility patients will be selected randomly

Exclusion criteria

Exclusion criteria: 1 Patients suffering from acute or chronic medical and systemic diseases such as tuberculosis heart disease hypothyroidism and hyperthyroidism 2 Patients having congenital anomalies of uterus such as unicornuate uterus uterus didelphys bicornuate uterus septate uterus and arcuate uterus 3 Patients having pelvic diseases such as fibroids benign or malignant tumors of ovary sexually transmitted diseases pelvic inflammatory disease endometriosis cervicitis and salpingitis

Design outcomes

Primary

MeasureTime frame
Evidence of ovulation assessed by follicular study and endometrial thickness by ultrasonography.Timepoint: Assessment will be done at baseline before initiation of treatment and at four weeks eight weeks and twelve weeks after initiation of treatment corresponding to three consecutive menstrual cycles.

Secondary

MeasureTime frame
Ovulation pattern assessed by ultrasonographyTimepoint: At the end of each menstrual cycle;Endometrial thickness assessed by ultrasonographyTimepoint: At the end of each menstrual cycle;Change in follicular development assessed by ultrasonographyTimepoint: At the end of each menstrual cycle;Conception during the study periodTimepoint: During treatment and follow up period;Regularity of menstrual cycle assessed by interval duration amount of flow and associated painTimepoint: At the end of each menstrual cycle and at the end of three menstrual cycles

Countries

India

Contacts

Public ContactDr Divya Pawar

YMT Ayurved College And Hospital, Kharghar, New Mumbai

pawardivya29794@gmail.com9011145777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026